Home Stock

Stock Research: Virbac

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Virbac

PAR:VIRP FR0000031577
98
  • Value
    84
  • Growth
    67
  • Safety
    Safety
    72
  • Combined
    96
  • Sentiment
    55
  • 360° View
    360° View
    98
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Virbac SA is a veterinarian pharmaceutical company specializing in developing and producing vaccines and medicines. It operates in the pharmaceutical industry, offering pet and livestock medications, as well as food and identification chips for pets. Production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. In the last fiscal year, the company had a market cap of $3,328 million, profits of $971 million, and revenue of $1,447 million, with 5620 employees.

more
Strongest Rank Stock Returns
Weakest Rank 360° View
Country France
Industry Pharmaceuticals
Size Small
Website corporate.virbac.com
Index
CAC All
SBF 120
Sound Pay Europe
Virbac stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 60 47 52
Growth
67 79 59 97
Safety
Safety
72 85 84 62
Sentiment
55 79 78 50
360° View
360° View
98 92 94 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
65 38 41 1
Opinions Change
50 62 94 50
Pro Holdings
n/a 80 61 100
Market Pulse
54 65 53 49
Sentiment
55 79 78 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 60 47 52
Growth
67 79 59 97
Safety Safety
72 85 84 62
Combined
96 81 80 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
88 59 63 69
Price vs. Earnings (P/E)
48 54 33 32
Price vs. Book (P/B)
69 45 43 43
Dividend Yield
51 41 43 49
Value
84 60 47 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
57 62 42 45
Profit Growth
52 67 37 83
Capital Growth
86 95 40 98
Stock Returns
38 35 96 100
Growth
67 79 59 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
39 78 76 63
Refinancing
91 50 61 44
Liquidity
62 68 79 48
Safety Safety
72 85 84 62

Similar Stocks

Discover high‑ranked alternatives to Virbac and broaden your portfolio horizons.

Grifols

MCE:GRF
Country: Spain
Industry: Biotechnology
Size: X-Large
Full Stock Analysis

Rubis

PAR:RUI
Country: France
Industry: Gas Utilities
Size: Large
Full Stock Analysis

TotalEnergies Gabon

PAR:EC
Country: France
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

L.D.C.

PAR:LOUP
Country: France
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews